3 out-of-favour investment trusts that Freetrade thinks are worth a second look

I love investment trusts, and many have been hammered during the stock market crash. I’m looking for bargain buys as they come storming back.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investment trusts, held in a Stocks and Shares ISA, let me invest in a range of companies without needing to evaluate every individual one. And I don’t have to put up with investment management companies trying to maximise their own profits rather than mine. No, when I buy, I become part-owner of the investment trust and the managers work for me.

Freetrade has identified three that seek out undervalued companies across the indexes, and I’m taking a look.

A contrarian investment trust

Fidelity Special Values (LSE: FSV) suffered a painful share price crunch in the first weeks of the pandemic. It quickly lost more than 50% of its start-of-year value, way worse than the FTSE indexes. It’s been muddling along since then, until the November spike came along. So far in the month, the price has soared 36%. But it is still down 15% year-to-date.

Net asset value per share (NAV) is estimated at 229p. So with the shares currently at 236p, we’re looking at a premium of 3%. It does look like the super-cheap opportunity has gone, but I’m still tempted to buy.

Fidelity describes itself as a “contrarian investment trust that thrives on volatility and uncertainty.” Sounds perfect for 2020. But what shares does it hold? Insurer Aviva is among FSV’s top stocks, and I rate that a top contrarian pick right now. Halfords is there too, another I see as undervalued.

Smaller companies

Freetrade’s next pick is Aberforth Smaller Companies (LSE: ASL). Small companies can be easily overlooked when investors are seeking the relative safety of blue-chip stocks. And those are what Aberforth looks for here.

Again, we see a November uptick, with the investment trust up 38%. The share price is down 22% so far in 2020, so maybe there’s more gain to come?

NAV stands at an estimated 1,229p, with the shares at 1,194p, at the time of writing. So we could pick up Aberforth Smaller Companies at a discount of 2.8%. Smaller stocks are likely to be more volatile though (but we’re talking 2020 here, so I guess anything goes).

I invested a lot in small-cap stocks in my earlier years, seeking growth rather than income. I see many as overlooked and undervalued now, and I think they’re likely to continue their recovery. Perhaps with some more ups and downs on the way.

Wide index spread

The last of the three is Lowland Investment Company (LSE: LWI), which has an interesting approach to sectors. This investment trust puts around half its cash into FTSE 100 companies. The rest goes into companies its managers think are undervalued, picked from across the smaller indexes.

I like the idea of mixing blue-chip stability with a bit of smaller-cap potential. So this one definitely appeals to me. And looking at top index holdings, I see Tesco and GlaxoSmithKline there. Those are both companies I’m bullish about for the long term.

The November spike struck here too. The Lowland share price has climbed 32% in November. But even so, the shares are still down 18% year-to-date. The current estimated NAV stands at 1,180p, with the shares on exactly the same price, as I write. So, in this case, there’s no discount or premium. But either way, I’m putting Lowland Investment on my list of investment trusts to examine more closely.

Alan Oscroft owns shares of Aviva. The Motley Fool UK has recommended GlaxoSmithKline and Tesco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »